Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
P/S ratio for Reata Pharmaceuticals (RETA)
P/S ratio as of May 2024 (TTM): 280
According to Reata Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 279.65. At the end of 2023 the company had a P/S ratio of 163.
P/S ratio history for Reata Pharmaceuticals from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 163 | -74.04% |
| 2022 | 628 | 652.15% |
| 2021 | 83.5 | -83.13% |
| 2020 | 495 | 93.42% |
| 2019 | 256 | 722.34% |
| 2018 | 31.1 | 102.24% |
| 2017 | 15.4 | 57.35% |
| 2016 | 9.78 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |